Fungal symptomatic intracranial aneurysm treated with a flow diverting stent: A case report.

Autor: Yosuke Fujimi, Tomohiko Ozaki, Nobuyuki Izutsu, Shin Nakajima, Yonehiro Kanemura, Tomoki Kidani, Saki Kawamoto, Naoki Nishizawa, Koji Kobayashi, Toshiyuki Fujinaka
Předmět:
Zdroj: Surgical Neurology International; 2024, Vol. 15, p1-6, 6p
Abstrakt: Background: Intracranial infectious aneurysms (IIAs) are very rare, and fungal aneurysms are infrequently reported. We report a case of an unruptured IIA caused by fungal rhinosinusitis and treated with a flow-diverting stent Case Description: An 81-year-old woman visited the ophthalmology department with impaired eye movement and ptosis and was placed under follow-up. A week later, she also developed a headache; magnetic resonance angiography revealed an aneurysm measuring 2 mm in the C4 portion of the right internal carotid artery. A 3-week follow-up with contrast-enhanced magnetic resonance imaging showed an increase in its size to 10 mm, and a contrast lesion was observed surrounding the right cavernous sinus. The patient started treatment with voriconazole and steroids on the same day. Ten weeks later, despite improvements in inflammation, the size of the aneurysm was unchanged; we, therefore, treated the aneurysm with a flow-diverting stent. Oculomotor nerve palsy improved, and the patient was discharged to a rehabilitation hospital 28 days after the placement, with a modified Rankin Scale of 4. A 1-year follow-up angiogram showed a partial decrease in the size of the aneurysm, with an O'Kelly-Marotta grading scale of B3. Conclusion: IIAs grow rapidly, and the risk of rupture is high due to the weakening of the aneurysmal wall. To reduce the risks of rupture and recurrence after treatment, the infection should be treated before inserting a flowdiverting stent. Flow-diverting stent placement may be an effective treatment for IIA once the original infection has been cured. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index